Literature DB >> 19327428

Relation of left atrial volume from three-dimensional computed tomography to atrial fibrillation recurrence following ablation.

Adam S Helms1, J Jason West, Amit Patel, Michael J Lipinski, J Michael Mangrum, J Paul Mounsey, John P Dimarco, John D Ferguson.   

Abstract

The effect of left atrial (LA) structural remodeling and dilatation on the outcome of ablation of atrial fibrillation (AF) remains unknown. We correlated potential prognostic markers of AF ablation, including LA volume from computed tomography, with AF recurrence after ablation. We studied 73 consecutive patients (52 with paroxysmal AF, 21 with persistent AF) undergoing AF ablation. LA volume was calculated by axial slice summation from 3-dimensional computed tomography. Follow-up was through 12 months, with success of ablation determined by electrocardiography and lack of symptoms (unless symptoms proved not AF by Holter monitor). Overall procedure success was 66% (including 15% repeat ablations, 12% on antiarrhythmics). Pulmonary vein isolation was performed, with additional linear ablation in 44 (60%). Mean LA volume (95% confidence interval) for those with recurrent AF was 119 ml (104 to 135) versus 98 ml (90 to 106) for no recurrence (p = 0.01, rank-sum test). Wide variation in LA volume occurred in the 2 groups, but, of the 15% of patients with very large LA volumes (>135 ml), 82% had recurrent AF. A cutpoint of 135 ml yields 36% sensitivity and 96% specificity for recurrence. In multivariable regression analysis, only LA volume and number of cardiovascular co-morbidities were associated with more recurrence (p = 0.02 and p = 0.03, respectively). In conclusion, LA volume varies greatly in those with and without successful AF ablations, mean LA volume is significantly larger in those with recurrence, and patients with LA volumes >135 ml are very likely to develop recurrent AF.

Entities:  

Mesh:

Year:  2009        PMID: 19327428     DOI: 10.1016/j.amjcard.2008.12.021

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

1.  Global left atrial strain in the prediction of sinus rhythm maintenance after catheter ablation for atrial fibrillation.

Authors:  Hirohiko Motoki; Kazuaki Negishi; Kenya Kusunose; Zoran B Popović; Mandeep Bhargava; Oussama M Wazni; Walid I Saliba; Mina K Chung; Thomas H Marwick; Allan L Klein
Journal:  J Am Soc Echocardiogr       Date:  2014-09-23       Impact factor: 5.251

2.  A simplified method to determine left atrial volume and transport function using multi-slice computed tomography in patients with atrial fibrillation: comparison with transthoracic echocardiography.

Authors:  Seung Yong Shin; Hwan Seok Yong; Jin Oh Na; Cheol Ung Choi; Seong Hwan Kim; Jin Won Kim; Eung Ju Kim; Seung-Woon Rha; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh; Young-Hoon Kim; Hong Euy Lim
Journal:  Int J Cardiovasc Imaging       Date:  2011-07-06       Impact factor: 2.357

Review 3.  [Cardiac computed tomography and ablation of atrial fibrillation].

Authors:  Martin Schmidt; F Straube; U Ebersberger; U Dorwarth; M Wankerl; J Krieg; E Hoffmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-12-05

Review 4.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

5.  Characteristic changes of volume and three-dimensional structure of the left atrium in different forms of atrial fibrillation: predictive value after ablative treatment.

Authors:  Sotirios Nedios; Min Tang; Mattias Roser; Natalia Solowjowa; Jin-Hong Gerds-Li; Eckart Fleck; Charalampos Kriatselis
Journal:  J Interv Card Electrophysiol       Date:  2011-06-11       Impact factor: 1.900

Review 6.  Atrial Remodelling : Role in Atrial Fibrillation Ablation.

Authors:  Herko Grubitzsch; Wilhelm Haverkamp
Journal:  J Atr Fibrillation       Date:  2012-12-16

7.  Left atrial appendage volume as a new predictor of atrial fibrillation recurrence after catheter ablation.

Authors:  Pedro Pinto Teixeira; Mário Martins Oliveira; Ruben Ramos; Pedro Rio; Pedro Silva Cunha; Ana Sofia Delgado; Ricardo Pimenta; Rui Cruz Ferreira
Journal:  J Interv Card Electrophysiol       Date:  2017-05-31       Impact factor: 1.900

8.  Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance.

Authors:  Alicia M Maceira; Juan Cosín-Sales; Michael Roughton; Sanjay K Prasad; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-11       Impact factor: 5.364

Review 9.  [Biomarkers and atrial fibrillation : Prediction of recurrences and thromboembolic events after rhythm control management].

Authors:  Jelena Kornej; Katja Schumacher; Daniela Husser; Gerhard Hindricks
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-05-14

Review 10.  Atrial remodeling and atrial fibrillation recurrence after catheter ablation : Past, present, and future developments.

Authors:  Sotirios Nedios; Frank Lindemann; Jordi Heijman; Harry J G M Crijns; Andreas Bollmann; Gerhard Hindricks
Journal:  Herz       Date:  2021-07-05       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.